Among 396 ovarian cancer tissue samples reported in this database, no difference (P=0.766) in the expression of DUSP6 was found between chemotherapy-resistant (42 samples) and chemotherapy- sensitive (284 samples) patients. Here, DUSP6 is linked to ovarian carcinoma.